The COVID-19 pandemic and the use of MS disease-modifying therapies

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Multiple sclerosis and related disorders 2020-04, Vol.39, p.102073-102073, Article 102073
Hauptverfasser:	Giovannoni, Gavin, Hawkes, Chris, Lechner-Scott, Jeannette, Levy, Michael, Waubant, Emmanuelle, Gold, Julian
Format:	Artikel
Sprache:	eng
Schlagworte:	Betacoronavirus - isolation & purification Coronavirus Infections - epidemiology Coronavirus Infections - immunology Coronavirus Infections - prevention & control COVID-19 Humans Multiple Sclerosis - drug therapy Multiple Sclerosis - epidemiology Multiple Sclerosis - immunology Multiple Sclerosis - virology Pandemics - prevention & control Pneumonia, Viral - epidemiology Pneumonia, Viral - immunology Pneumonia, Viral - prevention & control SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!